Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · IEX Real-Time Price · USD
12.66
+0.01 (0.08%)
At close: Mar 28, 2024, 4:00 PM
12.41
-0.25 (-1.97%)
After-hours: Mar 28, 2024, 5:17 PM EDT

Bioceres Crop Solutions Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year 202320222021202020192018201720162015
Revenue
415.71334.8209.53173.09160.61133.5446.8941.175.21
Revenue Growth (YoY)
24.16%59.79%21.05%7.77%20.27%184.83%13.88%690.79%-
Cost of Revenue
235.46208.36118.6493.5886.9677.0929.6130.63.84
Gross Profit
180.25126.4490.8879.5273.6456.4517.2710.571.37
Selling, General & Admin
11377.4847.638.3539.2435.2615.698.831.4
Research & Development
15.356.955.624.23.693.951.990.850.3
Other Operating Expenses
-1.083.280.280.31-0.37-0.61-0.05-0.02-0
Operating Expenses
127.2687.7153.542.8542.5738.617.639.661.7
Operating Income
52.9938.7337.3936.6731.0717.85-0.350.91-0.33
Interest Expense / Income
35.0825.8127.8532.741.4640.9510.198.250.88
Other Expense / Income
0.22.152.05-1.6-1.012.14-1.820.39-0.71
Pretax Income
17.7110.777.485.57-9.37-25.24-8.73-7.73-0.5
Income Tax
-1.0717.9714.352.216.99-10.93-2.82-1.860.69
Net Income
18.78-7.2-6.873.36-16.36-14.31-5.91-5.87-1.19
Shares Outstanding (Basic)
634239363028282828
Shares Outstanding (Diluted)
-4239363028282828
Shares Change
49.71%7.86%7.69%19.48%8.47%----
EPS (Basic)
0.30-0.17-0.170.09-0.60-0.39-0.21-0.21-0.04
EPS (Diluted)
0.30-0.17-0.170.09-0.60-0.39-0.21-0.21-0.04
Free Cash Flow
-19.39-24.08-12.616.4627.2913.47.1-1.99-1.12
Free Cash Flow Per Share
-0.31-0.57-0.320.180.900.480.25-0.07-0.04
Gross Margin
43.36%37.76%43.38%45.94%45.85%42.27%36.84%25.68%26.29%
Operating Margin
12.75%11.57%17.84%21.18%19.35%13.36%-0.75%2.22%-6.43%
Profit Margin
4.52%-2.15%-3.28%1.94%-10.19%-10.72%-12.60%-14.25%-22.93%
Free Cash Flow Margin
-4.66%-7.19%-6.02%3.73%16.99%10.04%15.14%-4.84%-21.48%
Effective Tax Rate
-6.03%166.83%191.83%39.65%-----
EBITDA
72.1845.7741.64336.9120.084.141.530.45
EBITDA Margin
17.36%13.67%19.85%24.84%22.98%15.04%8.83%3.72%8.65%
Depreciation & Amortization
19.399.196.264.734.834.372.671.010.07
EBIT
52.7936.5835.3338.2732.0915.711.470.520.38
EBIT Margin
12.70%10.93%16.86%22.11%19.98%11.76%3.13%1.27%7.23%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).